DaVita (DVA)
(Delayed Data from NYSE)
$141.55 USD
+1.30 (0.93%)
Updated Jul 12, 2024 03:59 PM ET
After-Market: $141.49 -0.06 (-0.04%) 7:58 PM ET
2-Buy of 5 2
A Value B Growth D Momentum A VGM
Brokerage Reports
DaVita Inc. [DVA]
Reports for Purchase
Showing records 181 - 200 ( 289 total )
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Raising Estimates Slightly as Capital Deployment Offsets Lower HCP
Provider: KEYBANC CAPITAL MARKETS
Analyst: GURDA J
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Reducing EPS Estimates Slightly on a Relatively Quiet Quarter
Provider: KEYBANC CAPITAL MARKETS
Analyst: GURDA J
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Raising Estimates Slightly on Guidance and Buybacks
Provider: KEYBANC CAPITAL MARKETS
Analyst: GURDA J
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
ALERT: Raises Full-Year Guidance Despite Slightly Light 1Q
Provider: KEYBANC CAPITAL MARKETS
Analyst: GURDA J